Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03856437 · ClinicalTrials.gov registry record · NA
A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination
A NA study, sponsored by University of Maryland, College Park.
- Completed
- Registry status
- NA
- Development phase
- 1,170
- Enrollment target
NCT03856437 is a NA study that has completed, run by University of Maryland, College Park. The registered enrollment target is 1,170 participants.
The verdict
NCT03856437, a NA study, has completed, sponsored by University of Maryland, College Park.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,170 participants
- Enrollment target
Study Summary
The goal of this study is to determine the effects of message framing (gain vs. loss) on African American parents' acceptance of the HPV vaccine and how such effects are moderated by parents' salient beliefs prior to message exposure. Participants are randomized into gain and loss conditions in which they view either gain-framed or loss-framed HPV vaccination messages. Key outcome variables include parents' attitudes and intentions toward vaccinating their children against HPV.
Interventions
- BEHAVIORAL HPV vaccination messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,170 participants |
| Start Date | 2021-01-22 |
| Est. Completion | 2022-04-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03856437
The ClinicalTrials.gov registry entry for NCT03856437 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, College Park, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HPV vaccination messages is the first listed.
NCT03856437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03856437 about?
NCT03856437 is a clinical study titled "A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination". The goal of this study is to determine the effects of message framing (gain vs. loss) on African American parents' acceptance of the HPV vaccine and how such effects are moderated by parents' salient beliefs prior to message exposure. Participants are randomized into gain and loss conditions in whic...
What is the current status of trial NCT03856437?
This trial is currently completed. It is a NA study. The enrollment target is 1,170 participants. The study started on 2021-01-22. Estimated completion is 2022-04-15.
What interventions are being tested in trial NCT03856437?
The interventions under investigation include: HPV vaccination messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT03856437?
This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.